BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22870146)

  • 1. Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.
    Lozano-Leon A; Perez-Quintela BV; Iglesias-García J; Lariño-Noia J; Varo E; Forteza J; Domínguez-Muñoz JE
    Oncol Lett; 2011 Jan; 2(1):161-166. PubMed ID: 22870146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients.
    Richards NG; Rittenhouse DW; Freydin B; Cozzitorto JA; Grenda D; Rui H; Gonye G; Kennedy EP; Yeo CJ; Brody JR; Witkiewicz AK
    Ann Surg; 2010 Sep; 252(3):499-505; discussion 505-6. PubMed ID: 20739850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer.
    Jeong J; Park YN; Park JS; Yoon DS; Chi HS; Kim BR
    Yonsei Med J; 2005 Aug; 46(4):519-25. PubMed ID: 16127777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
    Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
    Pare R; Soon PS; Shah A; Lee CS
    PLoS One; 2019; 14(4):e0214604. PubMed ID: 30998679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
    Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
    Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
    Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
    Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
    Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
    J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R.
    Smeenk HG; Erdmann J; van Dekken H; van Marion R; Hop WC; Jeekel J; van Eijck CH
    Dig Surg; 2007; 24(1):38-45. PubMed ID: 17369680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma.
    Mahipal A; Mcdonald MJ; Witkiewicz A; Carr BI
    Med Oncol; 2012 Mar; 29(1):134-9. PubMed ID: 21264542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
    Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.